Literature DB >> 19192169

Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.

Ya-Lin Li1, Jiao Wu, Ding Wei, Da-Wei Zhang, Hao Feng, Zhi-Nan Chen, Huijie Bian.   

Abstract

BACKGROUND/AIMS: Activated hepatic stellate cells (HSCs) are the crucial factor responsible for liver fibrosis and involved in development of hepatocellular carcinoma (HCC) by interaction with tumour cells. Newcastle disease virus (NDV) has the oncolytic characteristics of intrinsically selective replication in neoplasia cells and transformed cells. But, NDV replication in HSCs and effects on hepatic fibrosis have not been reported.
METHODS: We detected the effect of conditioned medium (CM) from human HCC cells on the activation of human HSC line, LX-2 by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and reverse transcriptase-polymerase chain reaction (RT-PCR). The replication of NDV was evaluated in LX-2 cells and primary-cultured mouse HSCs by flow cytometry or by a fluorescence microscope. Indices for hepatic fibrosis were determined in HSCs and a hepatic fibrosis mouse model by gelatin zymography, RT-PCR, Western blot and Sirius red staining after NDV infection. Colocalization of NDV virions and alpha-smooth muscle actin (alpha-SMA) were detected by double immunofluorescence staining. Detection of apoptosis was carried out in liver tissues of NDV-treated mice by the TdT-mediated dUTP nick-end labelling assay.
RESULTS: Tumour-CM and transforming growth factor-beta1 (TGF-beta1) could promote the proliferation and activation of LX-2 cells, indicated by the enhanced expression of alpha-SMA, collagen I, tissue inhibitor of metalloproteinase (TIMP)-1 and TGF-beta1. Activated HSCs facilitated the replication of NDV, thereby repressing the secretion of MMP, the expression of these indices for hepatic fibrosis and the expression of alpha-SMA and collagen fibrils in hepatic fibrosis of the mouse induced by carbon tetrachloride.
CONCLUSIONS: HCC cells promote the activation of HSCs and NDV attenuates the activation and represses the hepatic fibrosis by selective replication in activated HSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192169     DOI: 10.1111/j.1478-3231.2009.01971.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  11 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.

Authors:  Jennifer Altomonte; Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Irene Esposito; Katja Steiger; Annette Feuchtinger; Claus Hellerbrand; Roland M Schmid; Oliver Ebert
Journal:  Mol Ther       Date:  2013-08-13       Impact factor: 11.454

Review 3.  Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.

Authors:  Jennifer Altomonte; Oliver Ebert
Journal:  Front Oncol       Date:  2014-04-22       Impact factor: 6.244

Review 4.  Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients.

Authors:  Volker Schirrmacher
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 5.  Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!

Authors:  Volker Schirrmacher
Journal:  Biomedicines       Date:  2016-07-20

6.  miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3.

Authors:  Jie Xiong; Jianbo Ni; Congying Chen; Kezhou Wang
Journal:  Int J Mol Med       Date:  2020-06-23       Impact factor: 4.101

7.  Profiling of concanavalin A-binding glycoproteins in human hepatic stellate cells activated with transforming growth factor-β1.

Authors:  Yannan Qin; Yaogang Zhong; Ganglong Yang; Tianran Ma; Liyuan Jia; Chen Huang; Zheng Li
Journal:  Molecules       Date:  2014-11-28       Impact factor: 4.411

8.  Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.

Authors:  Hai-Yan Li; Di Ju; Da-Wei Zhang; Hao Li; Ling-Min Kong; Yanhai Guo; Can Li; Xi-Long Wang; Zhi-Nan Chen; Huijie Bian
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

Review 9.  Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies.

Authors:  Volker Schirrmacher; Philippe Fournier
Journal:  Front Oncol       Date:  2014-09-11       Impact factor: 6.244

10.  CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis.

Authors:  Wen-Pu Shi; Di Ju; Hao Li; Lin Yuan; Jian Cui; Dan Luo; Zhi-Nan Chen; Huijie Bian
Journal:  Int J Mol Sci       Date:  2018-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.